Clear Point Neuro, Inc. - Understand $clpt stock

$CLPT Market Cap: $350.9 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$30.43M

TTM

Gross Margin

60.33%

TTM

Net Earnings

-$18.15M

TTM

Current Assets

$34.33M

Q3 2024

Current Liabilities

$7.554M

Q3 2024

Current Ratio

454.46%

Q3 2024

Total Assets

$40.19M

Q3 2024

Total Liabilities

$11.19M

Q3 2024

Book Value

$29.00M

Q3 2024

Cash

$21.60M

Q3 2024

P/E

-19.34

Nov 29, 2024 EST

Free Cash Flow

-$9.036M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$23.96M	$20.55M	$16.30M	$12.83M	$11.22M	$7.350M	$7.380M	$5.750M	$4.590M	$3.600M	$3.930M	$5.060M	$3.820M	$2.670M	$2.600M	$1.950M	$0.00	$0.00
YoY Change	16.56%	26.09%	27.05%	14.34%	52.65%	-0.41%	28.35%	25.27%	27.5%	-8.4%	-22.33%	32.46%	43.07%	2.69%	33.33%			-100.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$23.96M	$20.55M	$16.30M	$12.83M	$11.22M	$7.350M	$7.380M	$5.750M	$4.590M	$3.600M	$3.930M	$5.060M	$3.820M	$2.670M	$2.600M	$1.950M	$0.00	$0.00
Cost Of Revenue	$10.34M	$7.020M	$5.008M	$3.709M	$3.830M	$2.430M	$2.900M	$2.640M	$1.990M	$1.930M	$1.420M	$560.0K	$660.0K	$20.00K	$0.00	$0.00		$0.00
Gross Profit	$13.61M	$13.53M	$11.29M	$9.120M	$7.380M	$4.920M	$4.480M	$3.110M	$2.610M	$1.680M	$2.510M	$4.500M	$3.160M	$2.650M	$2.600M	$1.950M		$0.00
Gross Profit Margin	56.83%	65.84%	69.27%	71.09%	65.78%	66.94%	60.7%	54.09%	56.86%	46.67%	63.87%	88.93%	82.72%	99.25%	100.0%	100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Selling, General & Admin	$24.35M	$9.611M	$8.761M	$5.270M	$9.060M	$7.860M	$8.000M	$7.970M	$8.370M	$8.040M	$7.060M	$6.030M	$4.830M	$4.700M	$3.600M	$2.920M	$1.410M	$530.0K
YoY Change	153.37%	9.7%	66.24%	-41.83%	15.27%	-1.75%	0.38%	-4.78%	4.1%	13.88%	17.08%	24.84%	2.77%	30.56%	23.29%	107.09%	166.04%	-43.01%
% of Gross Profit	178.87%	71.03%	77.59%	57.79%	122.76%	159.76%	178.57%	256.27%	320.69%	478.57%	281.27%	134.0%	152.85%	177.36%	138.46%	149.74%
Research & Development	$11.71M	$10.89M	$8.985M	$4.686M	$2.920M	$2.310M	$2.810M	$2.630M	$1.960M	$3.300M	$2.920M	$2.480M	$4.250M	$5.680M	$6.070M	$4.260M	$2.100M	$620.0K
YoY Change	7.48%	21.25%	91.74%	60.48%	26.41%	-17.79%	6.84%	34.18%	-40.61%	13.01%	17.74%	-41.65%	-25.18%	-6.43%	42.49%	102.86%	238.71%	113.79%
% of Gross Profit	86.01%	80.51%	79.58%	51.38%	39.57%	46.95%	62.72%	84.57%	75.1%	196.43%	116.33%	55.11%	134.49%	214.34%	233.46%	218.46%
Depreciation & Amortization	$626.0K	$244.0K	$159.0K	$334.0K	$140.0K	$110.0K	$120.0K	$160.0K	$210.0K	$380.0K	$430.0K	$420.0K	$350.0K	$270.0K	$170.0K	$80.00K	$20.00K
YoY Change	156.56%	53.46%	-52.4%	138.57%	27.27%	-8.33%	-25.0%	-23.81%	-44.74%	-11.63%	2.38%	20.0%	29.63%	58.82%	112.5%	300.0%
% of Gross Profit	4.6%	1.8%	1.41%	3.66%	1.9%	2.24%	2.68%	5.14%	8.05%	22.62%	17.13%	9.33%	11.08%	10.19%	6.54%	4.1%
Operating Expenses	$36.06M	$20.51M	$17.75M	$9.956M	$11.98M	$10.17M	$10.82M	$10.60M	$10.33M	$11.34M	$9.990M	$8.510M	$9.080M	$12.16M	$9.660M	$7.180M	$3.510M	$1.140M
YoY Change	75.86%	15.55%	78.24%	-16.89%	17.8%	-6.01%	2.08%	2.61%	-8.91%	13.51%	17.39%	-6.28%	-25.33%	25.88%	34.54%	104.56%	207.89%	-6.56%
Operating Profit	-$22.45M	-$16.33M	-$13.37M	-$6.220M	-$4.600M	-$5.250M	-$6.340M	-$7.490M	-$7.720M	-$9.660M	-$7.480M	-$4.010M	-$5.920M	-$9.510M	-$7.060M	-$5.230M		-$1.140M
YoY Change	37.44%	22.12%	115.02%	35.22%	-12.38%	-17.19%	-15.35%	-2.98%	-20.08%	29.14%	86.53%	-32.26%	-37.75%	34.7%	34.99%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Interest Expense	$386.0K	$81.00K	$973.0K	$1.444M	-$960.0K	-$920.0K	-$850.0K	$10.00K	$290.0K	$540.0K	$1.210M	-$2.750M	-$2.490M	-$350.0K	-$50.00K	-$200.0K	-$190.0K	-$130.0K
YoY Change	376.54%	-91.68%	-32.62%	-250.42%	4.35%	8.24%	-8600.0%	-96.55%	-46.3%	-55.37%	-144.0%	10.44%	611.43%	600.0%	-75.0%	5.26%	46.15%	333.33%
% of Operating Profit
Other Income/Expense, Net	-$29.00K	-$22.00K	-$63.00K	$882.0K	$10.00K	$0.00	$20.00K	$220.0K	$230.0K	$250.0K	-$820.0K	$0.00	$100.0K	$410.0K	$0.00	$0.00		$0.00
YoY Change	31.82%	-65.08%	-107.14%	8720.0%		-100.0%	-90.91%	-4.35%	-8.0%	-130.49%		-100.0%	-75.61%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Pretax Income	-$22.09M	-$16.43M	-$14.41M	-$6.780M	-$5.540M	-$6.160M	-$7.170M	-$8.070M	-$8.450M	-$4.520M	-$7.090M	-$5.880M	-$8.310M	-$9.450M	-$7.110M	-$5.430M	-$3.700M	-$800.0K
YoY Change	34.4%	14.05%	112.54%	22.38%	-10.06%	-14.09%	-11.15%	-4.5%	86.95%	-36.25%	20.58%	-29.24%	-12.06%	32.91%	30.94%	46.76%	362.5%	-15.79%
Income Tax	$8.000K	$0.00	$0.00	$0.00						$0.00	$0.00	$0.00	$0.00	$0.00	$50.00K	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$22.09M	-$16.44M	-$14.41M	-$6.782M	-$5.540M	-$6.160M	-$7.170M	-$8.070M	-$8.450M	-$4.520M	-$7.090M	-$5.880M	-$8.310M	-$9.450M	-$7.160M	-$5.430M	-$3.700M	-$800.0K
YoY Change	34.4%	14.05%	112.47%	22.42%	-10.06%	-14.09%	-11.15%	-4.5%	86.95%	-36.25%	20.58%	-29.24%	-12.06%	31.98%	31.86%	46.76%	362.5%	-15.79%
Net Earnings / Revenue	-92.21%	-79.97%	-88.41%	-52.86%	-49.38%	-83.81%	-97.15%	-140.35%	-184.1%	-125.56%	-180.41%	-116.21%	-217.54%	-353.93%	-275.38%	-278.46%
Basic Earnings Per Share	-$0.90	-$0.68	-$0.69
Diluted Earnings Per Share	-$0.90	-$0.68	-$695.0K	-$427.8K	-$421.0K	-$563.6K	-$926.4K	-$2.935M	-$4.495M	-$3.054M	-$4.958M	-$5.822M	-$20.78M	-$55.59M	-$55.08M	-$41.77M	-$28.46M	-$6.667M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Cash & Short-Term Investments	$23.14M	$37.49M	$54.11M	$20.10M	$5.700M	$3.100M	$9.290M	$3.320M	$5.410M	$9.240M	$3.520M	$1.620M	$150.0K	$1.580M	$2.570M	$9.920M
YoY Change	-38.28%	-30.72%	169.2%	252.63%	83.87%	-66.63%	179.82%	-38.63%	-41.45%	162.5%	117.28%	980.0%	-90.51%	-38.52%	-74.09%
Cash & Equivalents	$23.14M	$27.62M	$54.11M	$20.10M	$5.700M	$3.100M	$9.290M	$3.320M	$5.410M	$9.240M	$3.520M	$1.620M	$150.0K	$1.580M	$2.570M	$9.920M
Short-Term Investments	$0.00	$9.874M
Other Short-Term Assets	$1.910M	$1.723M	$508.0K	$240.0K	$360.0K	$210.0K	$190.0K	$140.0K	$100.0K	$30.00K	$170.0K	$110.0K	$20.00K	$20.00K	$60.00K	$20.00K
YoY Change	10.85%	239.17%	111.67%	-33.33%	71.43%	10.53%	35.71%	40.0%	233.33%	-82.35%	54.55%	450.0%	0.0%	-66.67%	200.0%
Inventory	$7.911M	$9.303M	$4.938M	$3.240M	$3.240M	$2.110M	$2.310M	$1.770M	$1.810M	$1.970M	$1.480M	$900.0K	$970.0K	$1.610M	$570.0K	$0.00
Prepaid Expenses
Receivables	$3.211M	$2.665M	$2.337M	$1.880M	$1.090M	$1.230M	$950.0K	$870.0K	$1.220M	$470.0K	$770.0K	$450.0K	$400.0K	$30.00K	$0.00	$10.00K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$36.17M	$51.18M	$61.89M	$25.46M	$10.38M	$6.650M	$12.75M	$6.090M	$8.530M	$11.71M	$5.940M	$3.080M	$1.540M	$3.240M	$3.190M	$9.950M
YoY Change	-29.32%	-17.31%	143.1%	145.28%	56.09%	-47.84%	109.36%	-28.6%	-27.16%	97.14%	92.86%	100.0%	-52.47%	1.57%	-67.94%
Property, Plant & Equipment	$4.953M	$2.701M	$2.780M	$3.060M	$820.0K	$380.0K	$270.0K	$330.0K	$440.0K	$480.0K	$900.0K	$1.290M	$1.220M	$980.0K	$990.0K	$860.0K
YoY Change	83.38%	-2.84%	-9.15%	273.17%	115.79%	40.74%	-18.18%	-25.0%	-8.33%	-46.67%	-30.23%	5.74%	24.49%	-1.01%	15.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$495.0K	$581.0K	$644.0K	$650.0K	$720.0K	$820.0K	$880.0K	$990.0K	$960.0K	$1.200M	$1.030M	$1.190M	$250.0K	$300.0K	$430.0K	$140.0K
YoY Change	-14.8%	-9.78%	-0.92%	-9.72%	-12.2%	-6.82%	-11.11%	3.13%	-20.0%	16.5%	-13.45%	376.0%	-16.67%	-30.23%	207.14%
Total Long-Term Assets	$6.489M	$4.310M	$3.689M	$4.060M	$1.550M	$1.210M	$1.150M	$1.310M	$1.410M	$1.680M	$1.930M	$2.470M	$1.490M	$1.320M	$1.480M	$1.010M
YoY Change	50.56%	16.83%	-9.14%	161.94%	28.1%	5.22%	-12.21%	-7.09%	-16.07%	-12.95%	-21.86%	65.77%	12.88%	-10.81%	46.53%
Total Assets	$42.66M	$55.49M	$65.58M	$29.52M	$11.93M	$7.860M	$13.90M	$7.400M	$9.940M	$13.39M	$7.870M	$5.550M	$3.030M	$4.560M	$4.670M	$10.96M
YoY Change
Accounts Payable	$393.0K	$272.0K	$427.0K	$300.0K	$970.0K	$500.0K	$760.0K	$1.550M	$700.0K	$1.000M	$1.380M	$1.960M	$4.040M	$3.500M	$470.0K	$740.0K
YoY Change	44.49%	-36.3%	42.33%	-69.07%	94.0%	-34.21%	-50.97%	121.43%	-30.0%	-27.54%	-29.59%	-51.49%	15.43%	644.68%	-36.49%
Accrued Expenses	$4.424M	$5.450M	$3.648M	$2.340M	$1.850M	$1.160M	$1.290M	$1.120M	$1.960M	$1.620M	$520.0K	$1.460M	$4.000M	$2.550M	$1.190M	$290.0K
YoY Change	-18.83%	49.4%	55.9%	26.49%	59.48%	-10.08%	15.18%	-42.86%	20.99%	211.54%	-64.38%	-63.5%	56.86%	114.29%	310.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due						$0.00	$2.000M	$0.00	$4.220M
YoY Change						-100.0%		-100.0%
Total Short-Term Liabilities	$7.430M	$6.788M	$4.753M	$3.200M	$3.830M	$2.010M	$4.400M	$3.020M	$7.650M	$4.920M	$10.09M	$6.310M	$14.59M	$8.640M	$5.540M	$3.630M
YoY Change	9.46%	42.82%	48.53%	-16.45%	90.55%	-54.32%	45.7%	-60.52%	55.49%	-51.24%	59.9%	-56.75%	68.87%	55.96%	52.62%
Long-Term Debt	$9.949M	$9.893M	$9.838M	$21.28M	$2.070M	$3.480M	$2.920M	$4.490M	$3.720M	$7.690M	$4.080M	$6.530M	$7.880M	$6.570M	$2.370M	$0.00
YoY Change	0.57%	0.56%	-53.77%	928.02%	-40.52%	19.18%	-34.97%	20.7%	-51.63%	88.48%	-37.52%	-17.13%	19.94%	177.22%
Other Long-Term Liabilities	$4.109M	$1.922M	$2.203M	$2.660M	$1.430M	$860.0K	$750.0K	$650.0K	$540.0K	$880.0K	$530.0K	$570.0K	$2.400M	$4.680M	$6.650M	$9.090M
YoY Change	113.79%	-12.76%	-17.18%	86.01%	66.28%	14.67%	15.38%	20.37%	-38.64%	66.04%	-7.02%	-76.25%	-48.72%	-29.62%	-26.84%
Total Long-Term Liabilities	$14.06M	$11.82M	$12.04M	$23.94M	$3.500M	$4.340M	$3.670M	$5.140M	$4.260M	$8.570M	$4.610M	$7.100M	$10.28M	$11.25M	$9.020M	$9.090M
YoY Change	18.98%	-1.88%	-49.7%	584.0%	-19.35%	18.26%	-28.6%	20.66%	-50.29%	85.9%	-35.07%	-30.93%	-8.62%	24.72%	-0.77%
Total Liabilities	$21.49M	$18.60M	$16.79M	$27.14M	$7.340M	$6.350M	$8.070M	$8.160M	$11.92M	$13.49M	$14.71M	$13.42M	$24.87M	$19.90M	$14.56M	$12.72M
YoY Change	15.51%	10.77%	-38.12%	269.75%	15.59%	-21.31%	-1.1%	-31.54%	-11.64%	-8.29%	9.61%	-46.04%	24.97%	36.68%	14.47%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	24.61M shares	24.18M shares	20.73M shares
Diluted Shares Outstanding	24.61M shares	24.18M shares	20.73M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $350.88 Million

About ClearPoint Neuro, Inc.

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 107 full-time employees. The company went IPO on 2019-07-03. The firm provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. The company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. The company also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES Beyond Air, Inc. ZYNEX INC IRADIMED CORP Sight Sciences, Inc. SeaSpine Holdings Corp Semler Scientific, Inc. ZimVie Inc.